Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-60
SponsorJSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH

About this trial

Dietary fiber are components in foods that are not digested by human gastrointestinal enzymes (alpha amylase and alpha glucosidase) but are instead broken down and fermented by gut microbes. The byproducts generated during fermentation in the large intestine, primarily short-chain fatty acids (SCFA), bile acids, indoles, and their derivatives, circulate through the circulatory system to the liver, lungs, brain, adipose tissue, and muscles, where they modulate metabolism (suppress lipogenesis and alleviate insulin resistance) and immune function. Individuals who are overweight or obese frequently exhibit gut dysbiosis, characterized by lower SCFA producing commensals. This condition predisposes them to metabolic disorders such as insulin resistance, dyslipidemia, and hypertension, and contributes to conditions including type 2 diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease. Preclinical and clinical research have demonstrated that the consumption of fiber-rich foods maintains or restores gut microbiota health and diminishes the risk of metabolic disorders. Kodo millet (Paspalum scrobiculatum), a small millet, is rich in dietary fiber and we have developed a palatable kodo millet porridge beverage enriched with polyphenols and dietary fiber. The purpose of this study is to examine the effects of consuming Kodo millet porridge beverage as a nutritional supplement for 3 months, on gut microbiome richness (composition and diversity) and metabolic health in overweight or obese people.

Eligibility criteria

Qualifiers

Adults aged 20-60 years.

Willingness to provide informed consent.

Willingness to consume Kodo millet porridge daily for 12 weeks.

No planned changes in diet or physical activity during the study.

Disqualifiers

Known allergies to millet or any porridge ingredients.

Individuals who are taking on-counter dietary fiber and probiotics supplements

History of any chronic gastrointestinal diseases (e.g., IBD, gastritis, irritable bowel syndrome).

Pregnant or lactating women.

Trial design

Treatments tested in this trial

  • Kodo Millet Porridge Beverage

Treatment groups

50 Participants
are divided into 1 treatment group